Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 15
Original Research
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,516 | Dovepress* | 4,114+ | 637 | 4,751 | |
| PubMed Central* | 402 | 154 | 556 | ||
| Totals | 4,516 | 791 | 5,307 | ||
| *Since 3 December 2020 | |||||
View citations on PubMed Central and Google Scholar